Understanding the underlying factors and mechanisms involved in regulating immune protection by CD4+ T cells from FRT will provide a foundation of information essential for developing therapeutic tools to protect women against gynecological cancers and sexually transmitted infections as women age in the years following menopause. This evidence concerns the gene CD4 and sexually transmitted disease.